The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1412
March 18, 2013
View Complete Issue         Table of Contents 2019 
A New Low-Dose Levonorgestrel-Releasing IUD (Skyla)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A New Low-Dose Levonorgestrel-Releasing IUD (Skyla)
March 18, 2013 (Issue: 1412)
The FDA recently approved Skyla (Bayer), the first new intrauterine device (IUD) in the US in 12 years. It releases levonorgestrel, a synthetic progestin, over a period of 3 years. A table summarizing contraceptive methods available in the US...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: A New Low-Dose Levonorgestrel-Releasing IUD (Skyla)
Article code: 1412a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.